Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Alberto Revelli, Simona Casano, Francesca Salvagno, Luisa Delle Piane, Alberto Revelli, Simona Casano, Francesca Salvagno, Luisa Delle Piane

Abstract

In the last decades, several steps have been made aiming at rendering human IVF more successful on one side, more tolerable on the other side. The "mild" ovarian stimulation approach, in which a lower-than-average dose of exogenous gonadotropins is given and gonadotropin treatment is started from day 2 to 7 of the cycle, represents a significant step toward a more patient's friendly IVF. However, a clear view of its virtues and defects is still lacking, because only a few prospective randomized trials comparing "mild" vs. conventional stimulation exist, and they do not consider some important aspects, such as, e.g., thawing cycles. This review gives a complete panorama of the "mild" stimulation philosophy, showing its advantages vs. conventional ovarian stimulation, but also discussing its disadvantages. Both patients with a normal ovarian responsiveness to exogenous gonadotropins and women with a poor ovarian reserve are considered. Overall, we conclude that the level of evidence supporting the use of "mild" stimulation protocols is still rather poor, and further, properly powered prospective studies about "mild" treatment regimens are required.

References

    1. Macklon NS, Stouffer RL, Giudice LC, Fauser BCJM. The Science behind 25 years of Ovarian Stimulation for In Vitro Fertilization. Endocr Rev. 2006;27(2):170–207. doi: 10.1210/er.2005-0015.
    1. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev. 2000;21(2):200–214. doi: 10.1210/er.21.2.200.
    1. Fauser BCJM, Van Heusden AM. Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev. 1997;18(1):71–106. doi: 10.1210/er.18.1.71.
    1. Hohmann FP, Laven JSE, de Jong FH, Eijkemans MJ, Fauser BCJ. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod. 2001;16(5):846–854. doi: 10.1093/humrep/16.5.846.
    1. Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC, Macklon NS. Contemporary pharmacogical manipulation in assisted reproduction. Drugs. 2004;64(3):297–322. doi: 10.2165/00003495-200464030-00005.
    1. Huirne JA, Homburg R, Lambalk CB. Are GnRH antagonists comparable to agonists for use in IVF? Hum Reprod. 2007;22(11):2805–2813. doi: 10.1093/humrep/dem270.
    1. Daya S. Gonadotropin releasing hormone agonist protocols for pituitary desensitisation in in vitro fertilization and gamete intrafallopian transfer cycles. Cochrane Database Syst Rev. 2000. p. CD001299.
    1. Ubaldi F, Rienzi L, Baroni E, Ferrero S. Iacobelli M, Minasi MG, Sapienza F, Romano S, Colasant A, Litwicka K, Greco E. Hopes and facts about mild ovarian stimulation. Reprod BioMed Online. 2007;14(6):675–681. doi: 10.1016/S1472-6483(10)60667-0.
    1. Macklon NS, Fauser BCJM. Mild stimulation in in vitro fertilization. Ann N Y Acad Sci. 2003;997:105–111. doi: 10.1196/annals.1290.012.
    1. Nargund J, Fauser BCJM, Macklon NS, Ombelet W, Nygren K, Frydman R. The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod. 2007;11(14):2801–2504. doi: 10.1093/humrep/dem285.
    1. Fernandez-Shaw S, Pèrez Esturo N, Cercas Dunque R, Pons Mallol I. Mild IVF using GNRH agonist long protocol is possible: comparing stimulations with 100 UI vs. 150 UI recombinant FSH at starting dose. J Assist Reprod Genet. 2009;26(2-3):75–82. doi: 10.1007/s10815-008-9289-z.
    1. Al-Inany H, Aboulghar M. GnRH antagonist in assisted reproduction: a Cochrane Review. Hum Reprod. 2002;17(4):874–885. doi: 10.1093/humrep/17.4.874.
    1. Hayden C. GnRH analogues: applications in assisted reproductive techniques. Eur J Endocrinol. 2008;159(1):17–25. doi: 10.1530/EJE-08-0354.
    1. Griesinger G, Felberbaum R, Diedrich K. GnRH antagonist in ovarian stimulation: a treatment regimen of clinicians' second choise? Data from the Germany national IVF registry. Hum Reprod. 2005;20(9):2373–2375. doi: 10.1093/humrep/dei086.
    1. Engel JB, Griesinger G, Schultze-Mosgau A, Felberbaum R, Diedrich K. GnRH agonist and antagonist in assisted reproduction: pregnancy rate. Reprod BioMed Online. 2006;13(1):84–87. doi: 10.1016/S1472-6483(10)62019-6.
    1. Kolibianakis EM, Collins I, Tarlatzis BC, Devroey P, Griesinger G. Among patients treated for IVF with gonadotrophins and GnRH analogues is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12a(6):651–671. doi: 10.1093/humupd/dml038.
    1. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006;19(3):CD001750.
    1. Hohmann FP, Macklon NS, Fauser BC. A randomized comparison of two ovarian stimulation protocols with gonadotropine-releasing hormone (GnRH) antagonist co-treatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. J Clin Endocrinol Metab. 2003;88(1):166–173. doi: 10.1210/jc.2002-020788.
    1. van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, Fauser BC, Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online. 2006;13(4):476–480. doi: 10.1016/S1472-6483(10)60633-5.
    1. Verberg MFG, Eijkemans MJC, Macklon NS, Heijen EMEW, Baart EB, Hohmann FP, Fauser BCJM, Broekmans FJ. The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update. 2009;15(1):5–12. doi: 10.1093/humupd/dmn053.
    1. Hejinen EMEW, Eijkemans MJC, De Klerk C, Polinder S, Beckers NGM, Klinkert ER, Broekmans FJ, Passchier J, Te Velde ER, Macklon NS, Fauser BCJM. A mild treatment strategy for in vitro fertilization: a randomised non inferiority trial. The Lancet. 2007;369(9563):743–749. doi: 10.1016/S0140-6736(07)60360-2.
    1. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans FJ. Predictors of ongoing pregnancy after single-embryo transfer following mild ovarian stimulation for IVF. Fertil Steril. 2008;89(5):1159–1165. doi: 10.1016/j.fertnstert.2007.05.020.
    1. Baart EB, Martini E, Eijkemans MJ, Van Ostal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder Ovarian stimulation for in vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomised controlled trial. Hum Reprod. 2007;22(4):980–988. doi: 10.1093/humrep/del484.
    1. Ertzeid G, Storeng R. The impact of ovarian stimulation on implantation and fetal development in mice. Hum Reprod. 2001;16(2):221–225. doi: 10.1093/humrep/16.2.221.
    1. Verberg MF, Eijkemans MJ, Macklon NS, Heijnen EM, Fauser BC, Broekmans F. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod. 2007;22(7):1919–1924. doi: 10.1093/humrep/dem089.
    1. Horcajadas JA, Mínguez P, Dopazo J, Esteban FJ, Domínguez F, Giudice LC, Pellicer A, Simón C. Controlled ovarian stimulation induces a functional genomic delay of the endometrium with potential clinical implications. J Clin Endocrinol Metab. 2008;93(11):4500–4510. doi: 10.1210/jc.2008-0588.
    1. Horcajadas JA, Díaz-Gimeno P, Pellicer A, Simón C. Uterine receptivity and the ramifications of ovarian stimulation on endometrial function. Semin Reprod Med. 2007;25(6):454–460. doi: 10.1055/s-2007-991043.
    1. Martínez-Conejero JA, Simón C, Pellicer A, Horcajadas JA. Is ovarian stimulation detrimental to the endometrium? Reprod Biomed Online. 2007;15(1):45–50.
    1. Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod. 1999;14(2):107–11.
    1. Check JH, Choe JK, Nazari A, Summers-Chase D. Ovarian hyperstimulation can reduce uterine receptivity. A case report. Clin Exp Obstet Gynecol. 2000;27(2):89–91.
    1. Check JH, Check ML . A case report demonstrating that follicle maturing drugs may create an adverse uterine environment even when not used for controlled ovarian hyperstimulation. Clin Exp Obstet Gynecol. 2001;28(4):217–218.
    1. Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91(3):749–766. doi: 10.1016/j.fertnstert.2007.12.077.
    1. Shanbhag S, Aucott L, Bhattacharya S, Hamilton MA, Mc Tavish AR. Interventions for " poor responders" to controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) Cochrane Database Syst Rev. 2007;24(1):CD004379.
    1. Tarlatzis BC, Zepiridis L, Grimbizis G, Bontis J. Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update. 2003;9(1):61–76. doi: 10.1093/humupd/dmg007.
    1. Land JA, Yarmolinskaya MI, Dumoulin JC, Evers JL. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril. 1996;65(5):961–965.
    1. Lekamge DN, Lane M, Gilchrist RB, Tremellen KP. Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve. J Assist Reprod Genet. 2008;25(11):515–521. doi: 10.1007/s10815-008-9266-6.
    1. Pantois C, Thotnton SJ, Speirs AL, Johnston I. Increasing the human menopausal gonadotropine dose- does the response really improve? Fertil Steril. 1990;53(3):436–439.
    1. Pal L, Jindal S, Witt BR, Santoro N. Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization. Fertil Steril. 2008;89(6):1694–1701. doi: 10.1016/j.fertnstert.2007.05.055.
    1. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17(2):121–155.
    1. Check JH. Mild ovarian stimulation. J Assist Reprod Genet. 2007;24(12):621–627. doi: 10.1007/s10815-007-9179-9.
    1. Check JH, Summers-Chase D, Yuan W, Horwath D, Wilson C. Effect of embryo quality on pregnancy outcome following single embryo transfer in women with a diminished egg reserve. Fertil Steril. 2007;87(4):749–756. doi: 10.1016/j.fertnstert.2006.11.001.
    1. Adashi EY. Clomiphene Citrate: mechanisms and sites of action- a hypothesis revisited. Fertil Steril. 1984;42(3):331–343.
    1. Craft I, Gorgy A, Hill J, Menon D, Podsiadly B. Will GnRH antagonists provide new hope for patients considered "difficult responders" to GnRH protocols? Hum Reprod. 1999;14(12):2959–2962. doi: 10.1093/humrep/14.12.2959.
    1. Takahashi K, Mukaida T, Tomiyana T, Goto T, Oka C. GnRH antagonist improved blastocyst quality and pregnancy outcome after multiple failures of IVF/ICSI-ET with a GnRH agonist protocol. J Assist Reprod Genet. 2004;21(9):317–322. doi: 10.1023/B:JARG.0000045470.68525.a4.
    1. D'Amato G, Caroppo E, Pasquadibisceglie A, Carone D, Vitti A, Vizziello GM. A novel protocol of ovulation induction with delayed gonadotrophin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril. 2004;81(6):1572–1577.
    1. Karimzadeh MA, Ahmadi S, Oskouian H, Rahmani E. Comparison of mild stimulation and conventional stimulation in ART outcome. Arch Gynecol Obstet. 2010;281(4):741–746. doi: 10.1007/s00404-009-1252-4.
    1. Lin YH, Hwang JL, Seow KM, Huang LW, Hsieh BC, Tzeng CR. Comparison of outcome of clomiphene citrate/human menopausal gonadotropine/cetrorelix protocol and buserelin long protocol- a randomized study. Gynecol Endocrinol. 2006;22(6):297–302. doi: 10.1080/09513590600702733.
    1. Williams SC, Gibbons WE, Muasher SJ, Oehninger S. Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropine with or without the addition of a gonadotropine-releasing hormone antagonist. Fertil Steril. 2002;78(5):1068–1072. doi: 10.1016/S0015-0282(02)03374-5.
    1. Yanaihara A, Yorimitsu T, Motoyama H, Ohara M, Kawamura T. The decrease of serum luteinizing hormone level by a gonadotropin-releasing hormone antagonist following the mild IVF stimulation protocol for IVF and its clinical outcome. J Assist Reprod Genet. 2008;25(4):115–118. doi: 10.1007/s10815-008-9205-6.
    1. Fauser BCJM, Devroey P, Yen SSC, Gosden R, Crowley WC, Baird DT, Bouchard P. Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum Reprod. 1999;14(11):2681–2686. doi: 10.1093/humrep/14.11.2681.
    1. Humaidan P, Papanikolaou EG, Tarlatzis BC. GnRHa to trigger final oocyte maturation: a time to reconsider. Hum Reprod. 2009;24(10):2389–2394. doi: 10.1093/humrep/dep246.
    1. Bristow RE, Karlan BY. Ovulation induction, infertility and ovarian cancer risk. Fertil Steril. 1996;66(4):499–507.
    1. Shoham Z. Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma. Where are we today? Fertil Steril. 1994;62(3):433–448.
    1. de Klerk C, Heijnen EM, Macklon NS, Duivenvoorden HJ, Fauser BC, Passchier J, Hunfeld JA. The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod. 2006;21(3):721–727. doi: 10.1093/humrep/dei395.
    1. Slade P, Emery J, Lieberman BA. A prospective, longitudinal study of emotions and relationships in in vitro fertilization treatment. Hum Reprod. 1997;12(1):183–190. doi: 10.1093/humrep/12.1.183.
    1. De Klerk C, Macklon NS, Hejinen EMEW, Eijkemans MJC, Fauser BCJM, Passchier J, Hunfeld JAM. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod. 2007;22(9):2554–2558. doi: 10.1093/humrep/dem171.
    1. Valbuena D, Jasper M, Remohi J, Pellicer A, Simon C. Ovarian stimulation and endometrial receptivity. Hum Reprod. 1999;14(2):107–11.
    1. Devroey P, Aboulghar M, Garcia-Velasco J, Griesinger G, Humaidan P, Kolibianakis E, Ledger W, Tomás C, Fauser BC. Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. Hum Reprod. 2009;24(4):764–774. doi: 10.1093/humrep/den468.
    1. Polinder S, Heijnen EMEW, Macklon NS, Habbema JDF, Fauser BJCM, Eijemans MJC. Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod. 2008;23(2):316–323. doi: 10.1093/humrep/dem372.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa